Fig. 6From: Development and validation of the potential biomarkers based on m6A-related lncRNAs for the predictions of overall survival in the lung adenocarcinoma and differential analysis with cuproptosisHeatmap analysis of the two risk sets in all patients.The figure shows that the differences of patient with N stage, T stage, Stage, Sex, Immune Score, and Cluster was respectively significant in two risk sets. The heatmap also shows the expression of the 10 prognostic m6A-related lncRNAs in the two risk sets.lncRNA, long non-coding RNA.“***”: P < 0.001, “**”: P < 0.01, “*”: P < 0.05Back to article page